Emmaus Life Sciences (EMMA) Work In Process (2018 - 2026)
Emmaus Life Sciences (EMMA) posted Work In Process of $21,000 for Q2 2026, down 88.7% from $186,000 a year earlier and down 96.4% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Work In Process (2018 - 2026) Analysis & Trends
At the end of FY2025, Emmaus Life Sciences' Work In Process came in at $26,000, down 85.9% from FY2024.
- Annual Work In Process has declined for three consecutive years, with a five-year compound annual growth rate of -48.5% (FY2020 to FY2025).
- In prior years, Emmaus Life Sciences' Work In Process was $184,000 in FY2024 (-1.1%), $186,000 in FY2023 (-63.7%), $513,000 in FY2022 (+346.1%) and $115,000 in FY2021 (-84.0%).
- The Q2 2026 figure stands as the lowest quarterly Work In Process in data going back to Q4 2018.
- On a year-over-year basis, Work In Process increased in 1 of the last eight quarters, with an average decline of 13.2%.
- The strongest year-over-year quarter for Work In Process in the past five years was Q4 2022, with growth of 346.1%; the weakest was Q3 2021, with a decline of 94.4%.
- According to Business Quant data, Work In Process for the three prior quarters was $582,000 (Q1 2026), $26,000 (Q4 2025) and $44,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21,000.00 |
| Mar 31, 2026 | 582,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 184,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | 285,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 186,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Jun 30, 2023 | 224,000.00 |
| Mar 31, 2023 | 280,000.00 |
| Dec 31, 2022 | 513,000.00 |
| Sep 30, 2022 | 278,000.00 |
| Jun 30, 2022 | 362,000.00 |
| Mar 31, 2022 | 132,000.00 |
| Dec 31, 2021 | 115,000.00 |
| Sep 30, 2021 | 70,000.00 |
API Access
Emmaus Life Sciences Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();